LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2) (EPMLARF)
LASER and Radiofrequency as Alternative Treatment of Vaginal Vulvar Atrophy in Women Treated for Breast Cancer
Sponsor: Federal University of São Paulo
Listed as NCT04081805, this NA trial focuses on Breast Cancer and Vaginal Atrophy and remains ongoing. Sponsored by Federal University of São Paulo, it has been updated 7 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
May 2025 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — May 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Oct 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2023 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Not Yet Recruiting NA
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Federal University of São Paulo
- Fundação de Amparo à Pesquisa do Estado de São Paulo
For direct contact, visit the study record on ClinicalTrials.gov .